[Management of acute exacerbation of chronic obstructive pulmonary disease (COPD)].
Gillissen
A
A
Robert Koch-Klinik, Klinikum St. Georg, Leipzig. adrian.gillissen@sanktgeorg.de
Buhl
R
R
Kardos
P
P
Kenn
K
K
Matthys
H
H
Pfister
R
R
Rabe
K F
KF
Sauer
R
R
Vogelmeier
C
C
Wettengel
R
R
Worth
H
H
Menz
G
G
D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003422:Critical Care; D003937:Diagnosis, Differential; D004562:Electrocardiography; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D010102:Oxygen Inhalation Therapy; D026741:Physical Therapy Modalities; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D012008:Recurrence; D012129:Respiratory Function Tests; D012138:Respiratory Therapy; D018570:Risk Assessment; D012307:Risk Factors; D013256:Steroids; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D013256:Steroids